✦ LIBER ✦

Su1085 Reduction of Fecal Calprotectin and Clinical Symptoms in the Phase 2 Study of Laquinimod for the Treatment of Active Moderate-to-Severe Crohn's Disease

✍ Scribed by D'Haens, Geert R.; Sandborn, William; Colombel, Jean-Frederic; Brown, Kurt; Haviv, Asi; Barkay, Hadas; Sakov, Anat; Feagan, Brian G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DOP059 Reduction of fecal calprotectin l

✍ D'Haens, G.; Sandborn, W.J.; Rutgeerts, P.; Colombel, J.F.; Brown, K.; Haviv, A. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 52 KB

Clinical trial: the effects of certolizu

✍ B. G. FEAGAN; M. C. REILLY; L. GERLIER; Y. BRABANT; M. BROWN; S. SCHREIBER 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

P300 Health related quality of life resu

✍ B. Feagan; C. Gasink; L.-L. Gao; M. Blank; J. Johanns; C. Guzzo; C.-F. Chiou; W. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 67 KB

A Multicenter, Randomized, Double-Blind,

✍ William J. Sandborn; Christopher Gasink; Long-Long Gao; Marion Blank; Jewel Joha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 145 KB